|
Deconstructing interactions between diet, microbiome, and immunity to gain mechanistic insight into health and disease |
1K99AI159227-01A1 |
|
NIAID |
2022 |
|
Implant Biofilm Mediated Immune Response |
1R01AI165958-01A1 |
|
NIAID |
2022 |
|
Metabolic regulators of Treg/Th17 balance in CNS autoimmunity |
1R01AI169075-01A1 |
|
NIAID |
2022 |
|
Alu dsRNAs as adjuvants for influenza vaccines |
1R21AI164107-01A1 |
|
NIAID |
2022 |
|
Allograft inflammatory factor-1 and immune tolerance |
1R21AI171739-01 |
|
NIAID |
2022 |
|
Novel Biofilm Paradigm Explaining Clinical Implant-Associated Illness. |
1R21AI171932-01 |
|
NIAID |
2022 |
|
B cell-targeted CAR-T treatment of CNS Autoimmunity |
1R21AI171994-01 |
|
NIAID |
2022 |
|
Human T cell Lymphotropic Virus Vaccine development |
1R41AI165061-01A1 |
|
NIAID |
2022 |
|
Nanoimmunotherapy for chronic immune-mediated diseases |
1R41AI170413-01 |
|
NIAID |
2022 |
|
Novel immunotherapy against MOG antibody disease |
1R43AI172705-01 |
|
NIAID |
2022 |